Neuroleptic malignant syndrome after haloperidol and fentanyl infusion in a patient with cancer with severe mineral imbalance

Journal of Palliative Medicine

Volumn 7, Issue 6, 2004, Pages 861-864

  Morita, Tatsuya ^a   Shishido, Hideki ^a   Tei, Yo ^a   Inoue, Satoshi ^a   Nagayama, Kenji ^b  

^a Seirei Mikatabara Hospital   (Japan)

^b Seirei Mikatabara Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DIAZEPAM; FENTANYL; FLURBIPROFEN; HALOPERIDOL; MORPHINE;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DELIRIUM; DIAPHORESIS; DISEASE COURSE; DRUG FEVER; DYSPHAGIA; ESOPHAGUS CANCER; HUMAN; HYPERTENSION; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; LABORATORY TEST; MALE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC EXAMINATION; PALLIATIVE THERAPY; TACHYCARDIA; TACHYPNEA; TREMOR; UNCONSCIOUSNESS;

EID: 11344282271     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2004.7.861     Document Type: Article

References (20)

1. Adnet P, Lestavel P, Krivosic-Horber R: Neuroleptic malignant syndrome. Br J Anaesth 2000;85:129-135.
2. Pelonero AL, Levenson JL, Pandurangi AK: Neuroleptic malignant syndrome: A review. Psychiatr Serv 1998;49:1163-1172.
3. Breitbart W, Jaramillo JR, Chochinov HM: Palliative and terminal care. In: Holland JC (ed): Psycho-oncology. New York: Oxford University Press, 1998, pp. 437-449.
4. Ashby MA, Martin P, Jackson KA: Opioid substitution to reduce adverse effects in cancer pain management. Med J Aust 1999;170:68-71.
5. Paix A, Coleman A, Lees J, Grigson J, Brooksbank M, Thorne D, Ashby M: Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain 1995;63:263-269.
6. Watanabe S, Pereira J, Hanson J, Bruera E: Fentanyl by continuous subcutaneous infusion for the management of cancer pain. A retrospective study. J Pain Symptom Manage 1998;16:323-326.
7. Chang J, Fish KJ: Acute respiratory arrest and rigidity after anesthesia with sufentanil: A case report. Anesthesiology 1985;63:710-711.
8. Epstein RH, Mendel HG, Witkowski TA, Waters R, Guarniari KM, Marr AT, Lessin JB: The safety and efficacy of oral transmucosal fentanyl citrate for preoperative sedation in young children. Anesth Analg 1996;83:1200-1205.
9. Streisand JB, Bailey PL, LeMaire L, Ashburn MA, Tarver SD, Varvel J, Stanley TH: Fentanyl-induced rigidity and unconsciousness in human volunteers. Anesthesiology 1993;78:629-634.
10. Viscomi CM, Bailey PL: Opioid-induced rigidity after intravenous fentanyl. Obstet Gynecol 1997;89:822-824.
11. Bloom FD, Segal N, Ling N, et al. Endrophines: Profound behavioral effects in rats suggest new etiological factors in mental illness. Science 1976;194:630-632.
12. Ang AW, Ko SM, Tan CH: Calcium, magnesium, and psychotic symptoms in a girl with idiopathic hypoparathyroidism. Psychosomat Med 1995;57:299-302.
13. Beumont PJV, Large M: Hypophosphataemia, delirium and cardiac arrhythmia in anorexia nervosa. Med J Aust 1991;155:519-522.
14. Flink EB: Magnesium deficiency. Etiology and clinical spectrum. Acta Med Scand Suppl 1981;647:125-137.
15. Knochel JP: The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med 1977;137:203-220.
16. Tanaka K, Akechi T, Yamazaki M, Hayashi R, Nishiwaki Y, Uchitomi Y: Neuroleptic malignant syndrome during haloperidol treatment in a cancer patient. A case report. Support Care Cancer 1998;6:536-538.
17. Zohar Y, Sabo R, Finkelstein Y, Korzets A: Neuroleptic malignant syndrome during perphenazine treatment in a patient with head and neck cancer: A case report. Otolaryngol Head Neck Surg 1992;106:206-208.
18. Chan-Tack KM: Neuroleptic malignant syndrome due to promethazine. South Med J 1999;92:1017-1018.
19. Harsch HH: Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases. J Clin Psychiatry 1987;48:328-333.
20. Lim R: Idiopathic hypoparathyroidism presenting as the neuroleptic malignant syndrome. Br J Hosp Med 1989;41:182.